Growing global burden of DKA

Global healthcare company Abbott, has announced new data that reveals a growing global burden of diabetic ketoacidosis (DKA). The findings also show significant gaps in

Read More »

GLP-1s and skeletal muscle loss

While GLP-1 receptor agonists (RAs) have transformed the management of Type 2 diabetes and obesity, concerns remain regarding their effects on skeletal muscle, particularly the

Read More »